Trial Information
99mTechnetium-MIBI SPECT-CT for Pre-operative Evaluation of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma; A Pilot Study
Inclusion Criteria:
- papillary thyroid cancer
Exclusion Criteria:
- pregnancy
- Bleeding abnormality
- Prior history of head and neck cancer
- can not perform 99mTechnetium-MIBI SPECT-CT
- can not perform 131I remnant Ablation
- Prior any head and neck surgery within 3 months
- Prior deep neck infection within 3 months
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
Diagnostic Tool Statistic (PPV , NPV , Sensitivity , Specificity , Accuracy )
Outcome Time Frame:
18 months
Safety Issue:
No
Principal Investigator
Napadon Tangjaturonrasme, Otolaryngologist
Investigator Role:
Principal Investigator
Investigator Affiliation:
Department of Otolaryngology , Faculty of Medicine , Chulalongkorn University
Authority:
Thailand: Ethical Committee
Study ID:
NapadonChula_01
NCT ID:
NCT00984191
Start Date:
March 2010
Completion Date:
November 2011
Related Keywords:
- Papillary Thyroid Cancer
- Papillary thyroid cancer
- 99mTechnetium MIBI SPECT CT
- preoperative
- cervical lymphadenopathy
- cervical metastasis
- Carcinoma
- Thyroid Neoplasms
- Carcinoma, Papillary
- Thyroid Diseases